Home Clinical Topics New FDA regulation for improving safety reporting in clinical trials discussed in...
Clinical TopicsDrugs and DevicesNewsWorkplace ManagementPatient SafetyWeb Exclusives

New FDA regulation for improving safety reporting in clinical trials discussed in The New England Journal of Medicine.

The June 8 edition of The New England Journal of Medicine includes “New FDA Regulation to Improve Safety Reporting in Clinical Trials.” Read here.

Previous articleMice study finds genetic link between lung cancer and emphysema
Next articlePCI with stent is a viable option for select group of patients

RELATED ARTICLES

Clinical Topics

Drug diversion in healthcare

Prevention and detection for nurses Special report to American Nurse Journal, supported by an educational grant from Fresenius Kabi USA. © 2021, HealthCom Media Takeaways: Drug diversion among...
Read more
Current Journal

Benefits of feedback for nurse leaders

Viewing feedback as a gift enhances career growth. Takeaways: Without feedback, beginning nurse leaders’ careers can be derailed Constructive feedback can lead to significant performance...
Read more
Current Journal

Individual nurse liability insurance

Understand your options Takeaways: Nurses are at risk for litigation or state board of nursing action against them. To protect themselves, nurse should learn about...
Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Early Release Articles

Powered by  HCM   www.HealthComMedia.com

© 2021 HealthCom Media All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder